Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01463046
Brief Title: Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

First Submitted : October 27, 2011
First Submitted that Met QC Criteria : October 27, 2011
First Posted : November 1, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : April 19, 2019
Last Update Posted : April 22, 2019